Maternal immunization with adjuvanted RSV prefusion F protein effectively protects offspring from RSV challenge and alters innate and T cell immunity

Respiratory syncytial virus (RSV) commonly causes severe respiratory tract infections in infants, peaking between 2–6 months of age; an age at which direct vaccination is unlikely to be effective. Maternal immunization can deliver high levels of antibodies to newborns, providing immediate protection...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Vaccine
Hlavní autoři: Eichinger, Katherine M., Kosanovich, Jessica L., Lipp, Madeline A., Perkins, Timothy N., Petrovsky, Nikolai, Marshall, Christopher, Yondola, Mark A., Empey, Kerry M.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8110191/
https://ncbi.nlm.nih.gov/pubmed/33129608
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2020.10.065
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky